If you want, you can send details about your upcoming scientific event by filling out the form on our Scientific events web site www.arpharm-e4ethics.org.Send
Dr. Stamen Bankovski General Manager, Astellas Pharma for Hungary, Bulgaria, and Romania. Shortly after graduating in 1995 the Medical university in Sofia, he started a long and successful career in the Pharma industry.
He gained wealth of experience in various sales and marketing roles, as well as market access & governmental affairs in several large International pharma companies. Since 2011 as Country or General manager he has led several organizations with increasing complexity.
In 2020, being among the founders of the Japan-Bulgaria Business Association, Dr. Bankovski was elected Deputy Chairman of the JBBA. In May 2022 he has been elected Chairman of the Managing board of ARPharM.
Dr. Krassimira Chemishanska is the General Manager of Amgen Bulgaria since the opening of the affiliate in 2009. Prior to her appointment at Amgen Bulgaria, she worked at different management positions in AstraZeneca Bulgaria, the last one being Marketing Director.
Dr. Krassimira Chemishanska graduated Medicine from the Medical University in Sofia and has acquired a MBA in General Management from the City University of Seattle and a Master Degree in Business Administration from the International Business School.
Since 2013 she is a member of ARPharM Board, and since 2011 member of the AmCham Board of Directors.
In 2015 she was elected for a President of American Chamber of Commerce.
Boryana Alexieva M.D is Government Affairs Patient engagement and advocacy Lead, Janssen – Pharmaceutical Companies of Johnson and Johnson
25 years of experience in many areas of healthcare, including pioneering and setting up a business for international innovative companies for medical devices and equipment in Bulgaria, as well as their implementation and management. She has held various positions in the pharmaceutical industry and extensive consulting experience. Experience in government structures related to the economics of healthcare and reimbursement, healthcare management, public health.
She has a master's degree in human medicine from the Medical University in Bulgaria, a degree in mathematics, as well as master's degree in healthcare management.
Dr. Ana Tsakova is Managing Director of Merck Bulgaria since 2016. She has 20 years of experience in the pharmaceutical industry, starting her career at MSD as Medical representative. In 2007 she continued her professional experience in Actavis EAD and in 2011 she joined the team of Merck Bulgaria, taking the lead of it later on in 2016. She has held various positions in marketing, sales and management, growing in accountability, being responsible for businesses across different fields of medicine.
Dr. Ana Tsakova is a medical doctor with a degree from the Medical University Sofia in 1999 and later obtained her Ph.D. in Pharmacology in the Department of Pharmacology and Toxicology in the same University. In 2004 she obtained an MBA degree from the Sofia University's Faculty of Economics. Her interests are in the fields of medicine, healthcare and innovation.
Dr. Sava Todorov is a Market Access Manager at MSD Bulgaria. In the last few years, he has played key roles in the pharmaceutical industry in Bulgaria and the region of Eastern Europe. He has 8 years of experience in rare diseases, in which he has worked on the implementation of several digital tools to support health professionals and patients and valuable health care. He has more than 15 years of experience in the pharmaceutical industry.
Sava Todorov is a biologist, and holds a PhD in Medical Anthropology.
Mr. Sabry has extensive experience in healthcare. Since January 2003, he has held successive positions and functions in four multinational pharmaceutical companies. He joined Roche in 2015 and held diverse leadership positions in the company. His latest role before Joining Roche Bulgaria has been the Roche Levant Countries Head & General Manager (Lebanon, Jordan, Syria & Palestine).
Hesham Sabry graduated in Pharmaceutical Sciences from the University of Cairo, Egypt. He later earned a master's degree in business administration with a specialization in marketing from the University of Leicester, UK.
Mr. Todor Kesimov is General Manager of Takeda Bulgaria EOOD. He joins Takeda in 2012 and since then he has been assigned at various positions in the field of finance and logistics in Takeda’s representative office in Bulgaria, as well as with responsibilities for various neighbouring countries. In the period 2017-2018 Mr Kesimov leads Takeda’s Finance department for the Balkan region. Since the beginning of 2018 Mr Kesimov is General Manager of Takeda’s representative office in Bulgaria. Currently, after Takeda acquired Shire, Todor Kesimov is General Manager of Takeda Bulgaria EOOD.
Todor has graduated from Regent's Business School London in 2007, BA in International Business and Finance.
Since 2020 Todor Kesimov is a member of the Management board of the Japan-Bulgaria Business Association.
Mr. Deyan Denev has been the Director of ARPharM since October 2003. Lawyer by education, graduated from Sofia University “St. Kliment Ohridski”, expert in pharmaceutical legislation and drug policy. As Director of the association, he leads the activities of the pharmaceutical research-based industry on key issues concerning drug policy and regulations, intellectual property and the development of the pharmaceutical market. Deyan Denev is a member of the Transparency Commission as a representative of the pharmaceutical industry in Bulgaria from 2008 to 2013 and represents the Confederation of Industrialists and Employers in Bulgaria in the Supervisory Board of the NHIF from January 2014 to January 2015.
He is a member of the Special Working Group for Central and Eastern Europe of the European Federation of Pharmaceutical Industries and Associations and Chairman of the Board of the Bulgarian Medicines Verification Organisation (BgMVO) in 2021.